NRIP1
Basic information
Region (hg38): 21:14961235-15065936
Links
Phenotypes
GenCC
Source:
- congenital anomalies of kidney and urinary tract 3 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital anomalies of the kidney and urinary tract 3 | AD | Renal | Evidence or clinical applicability is unclear | Neurologic; Renal | 21743468; 28381549 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NRIP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 10 | 48 | |||
missense | 111 | 17 | 11 | 139 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 115 | 56 | 22 |
Variants in NRIP1
This is a list of pathogenic ClinVar variants found in the NRIP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-14964724-ATTCT-A | not specified | Uncertain significance (Jan 08, 2024) | ||
21-14964728-T-A | Inborn genetic diseases | Uncertain significance (Jun 05, 2023) | ||
21-14964738-G-A | Congenital anomalies of kidney and urinary tract 3 • NRIP1-related disorder | Likely benign (Jan 18, 2024) | ||
21-14964745-C-T | NRIP1-related disorder | Uncertain significance (Dec 26, 2023) | ||
21-14964750-C-T | Inborn genetic diseases | Uncertain significance (Jan 16, 2024) | ||
21-14964754-G-C | Congenital anomalies of kidney and urinary tract 3 | Uncertain significance (May 20, 2023) | ||
21-14964763-A-C | NRIP1-related disorder | Likely benign (May 22, 2023) | ||
21-14964767-T-C | NRIP1-related disorder | Benign (Nov 03, 2023) | ||
21-14964779-G-A | NRIP1-related disorder | Benign (Oct 22, 2023) | ||
21-14964781-T-C | Inborn genetic diseases • NRIP1-related disorder | Conflicting classifications of pathogenicity (Oct 03, 2023) | ||
21-14964785-T-G | NRIP1-related disorder | Likely benign (Sep 26, 2022) | ||
21-14964790-G-A | Benign (Apr 01, 2024) | |||
21-14964792-G-A | Inborn genetic diseases | Uncertain significance (Oct 10, 2023) | ||
21-14964808-T-C | Uncertain significance (Apr 18, 2022) | |||
21-14964829-T-C | Inborn genetic diseases | Uncertain significance (Oct 24, 2023) | ||
21-14964844-A-C | Uncertain significance (Jul 22, 2022) | |||
21-14964855-T-G | Inborn genetic diseases | Uncertain significance (Nov 29, 2021) | ||
21-14964863-A-G | NRIP1-related disorder | Benign (Jan 15, 2024) | ||
21-14964880-T-C | Benign (Sep 04, 2023) | |||
21-14964890-C-G | Inborn genetic diseases • NRIP1-related disorder | Conflicting classifications of pathogenicity (Dec 26, 2023) | ||
21-14964899-A-T | Inborn genetic diseases | Uncertain significance (Jun 30, 2023) | ||
21-14964906-G-C | Inborn genetic diseases | Uncertain significance (Jul 26, 2022) | ||
21-14964931-C-T | Inborn genetic diseases | Uncertain significance (Nov 30, 2022) | ||
21-14964949-G-C | Inborn genetic diseases | Uncertain significance (Aug 27, 2023) | ||
21-14964954-G-A | Inborn genetic diseases | Uncertain significance (Oct 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NRIP1 | protein_coding | protein_coding | ENST00000400202 | 1 | 103766 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00606 | 125698 | 0 | 38 | 125736 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.460 | 610 | 579 | 1.05 | 0.0000277 | 7665 |
Missense in Polyphen | 198 | 201.32 | 0.98353 | 2754 | ||
Synonymous | -1.07 | 240 | 220 | 1.09 | 0.0000112 | 2226 |
Loss of Function | 4.66 | 4 | 32.8 | 0.122 | 0.00000177 | 465 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000675 | 0.000675 |
Ashkenazi Jewish | 0.0000999 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000973 | 0.0000791 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of ARNTL/BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. {ECO:0000269|PubMed:10364267, ECO:0000269|PubMed:11509661, ECO:0000269|PubMed:11518808, ECO:0000269|PubMed:12554755, ECO:0000269|PubMed:15060175, ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:7641693}.;
- Pathway
- Adipogenesis;Aryl Hydrocarbon Receptor;Pregnane X Receptor pathway;Vitamin D Receptor Pathway;Nuclear Receptors Meta-Pathway;Ovarian Infertility Genes;Transcription factor regulation in adipogenesis;Liver steatosis AOP;mechanism of gene regulation by peroxisome proliferators via ppara;Circadian Clock;Coregulation of Androgen receptor activity;FOXA1 transcription factor network;Validated nuclear estrogen receptor alpha network;Retinoic acid receptors-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.0754
- rvis_EVS
- 1.39
- rvis_percentile_EVS
- 94.64
Haploinsufficiency Scores
- pHI
- 0.826
- hipred
- Y
- hipred_score
- 0.762
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.112
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nrip1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;ovarian follicle rupture;circadian rhythm;lipid storage;androgen receptor signaling pathway;circadian regulation of gene expression;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;cellular response to estradiol stimulus
- Cellular component
- histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;nucleolus;nuclear speck
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;transcription coactivator activity;transcription corepressor activity;protein binding;estrogen receptor binding;nuclear hormone receptor binding;glucocorticoid receptor binding;histone deacetylase binding;retinoid X receptor binding;androgen receptor binding